View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2032-11-15 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 1250.00 |
| Coupon | 4.5 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 1250.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Pfizer Inc. corporate note has a 4.50% fixed rate coupon paid on a semi-annual basis. It was issued on November 21, 2025 with an issue size of 1250.00 million USD and matures on November 15, 2032 with a last coupon date of May 15, 2032. |
Pfizer Inc., founded in 1849 and headquartered in New York City, is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and vaccines. Pfizer's notable products include vaccines such as Comirnaty for COVID-19 and treatments like Lyrica and Ibrance, making it a key player in the healthcare industry.